PODCAST: Gut check

April 1, 2015

Among recent research on nonpharmacologic therapies for the often baffling sequelae accompanying autism, some of the most intriguing explores clues to its etiology. A.J. Russo, PhD, recently sat down exclusively with Contemporary Pediatrics to discuss his newly published study of how probiotics impact gut flora and biomarkers such as copper in children with autism-looking for their correlations with GI disease and behavioral symptom severity.

Among recent research on nonpharmacologic therapies for the often baffling sequelae accompanying autism, some of the most intriguing explores clues to its etiology. A.J. Russo, PhD, recently sat down exclusively with Contemporary Pediatrics to discuss his newly published study of how probiotics impact gut flora and biomarkers such as copper in children with autism-looking for their correlations with GI disease and behavioral symptom severity.  Russo AJ. Decreased plasma myeloperoxidase associated with probiotic therapy in autistic children. Clin Med Insights Pediatr. 2015 Feb 3;9:13-17.

Find Dr. Russo's study here.